Simon Quick Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-347
| Closed | -$268K | – | 432 |
|
|
2026
Q1 | $268K | Sell |
347
-57
| -14% | -$43.6K | 0.01% | 321 |
|
|
2025
Q4 | $312K | Buy |
404
+23
| +6% | +$15.6K | 0.01% | 309 |
|
|
2025
Q3 | $214K | Buy |
+381
| New | +$215K | 0.01% | 377 |
|
|
2025
Q2 | – | Sell |
-1,150
| Closed | -$730K | – | 587 |
|
|
2025
Q1 | $730K | Buy |
1,150
+132
| +13% | +$90.8K | 0.04% | 218 |
|
|
2024
Q4 | $725K | Sell |
1,018
-39
| -4% | -$32.7K | 0.04% | 195 |
|
|
2024
Q3 | $1.11M | Buy |
1,057
+476
| +82% | +$530K | 0.07% | 133 |
|
|
2024
Q2 | $611K | Sell |
581
-99
| -15% | -$96K | 0.04% | 187 |
|
|
2024
Q1 | $654K | Buy |
680
+231
| +51% | +$220K | 0.05% | 168 |
|
|
2023
Q4 | $394K | Buy |
449
+14
| +3% | +$11.5K | 0.03% | 200 |
|
|
2023
Q3 | $358K | Buy |
435
+70
| +19% | +$55K | 0.03% | 208 |
|
|
2023
Q2 | $262K | Sell |
365
-2
| -0.5% | -$1.54K | 0.02% | 231 |
|
|
2023
Q1 | $302K | Buy |
367
+84
| +30% | +$63.4K | 0.03% | 210 |
|
|
2022
Q4 | $204K | Buy |
+283
| New | +$209K | 0.02% | 222 |
|
|
2022
Q2 | – | Sell |
-33
| Closed | -$23K | – | 345 |
|
|
2022
Q1 | $23K | Buy |
33
+1
| +3% | +$633 | 0.01% | 269 |
|
|
2021
Q4 | $20K | Sell |
32
-5
| -14% | -$3.07K | 0.01% | 287 |
|
|
2021
Q3 | $22K | Buy |
37
+5
| +16% | +$3.1K | 0.01% | 309 |
|
|
2021
Q2 | $17K | Sell |
32
-21
| -40% | -$10.6K | ﹤0.01% | 347 |
|
|
2021
Q1 | $25K | Hold |
53
| – | – | 0.01% | 341 |
|
|
2020
Q4 | $26K | Sell |
53
-3
| -5% | -$1.62K | 0.01% | 312 |
|
|
2020
Q3 | $31K | Sell |
56
-4
| -7% | -$2.42K | 0.01% | 263 |
|
|
2020
Q2 | $37K | Hold |
60
| – | – | 0.01% | 226 |
|
|
2020
Q1 | $29K | Sell |
60
-67
| -53% | -$27.6K | 0.01% | 251 |
|
|
2019
Q4 | $48K | Buy |
+127
| New | +$42.7K | 0.02% | 234 |
|
|
2019
Q3 | – | Sell |
-31
| Closed | -$9.7K | – | 489 |
|
|
2019
Q2 | $9.7K | Buy |
+31
| New | +$10.3K | ﹤0.01% | 229 |
|
|
2018
Q4 | – | Sell |
-12
| Closed | -$5K | – | 363 |
|
|
2018
Q3 | $5K | Hold |
12
| – | – | ﹤0.01% | 261 |
|
|
2018
Q2 | $4K | Hold |
12
| – | – | ﹤0.01% | 302 |
|
|
2018
Q1 | $4K | Hold |
12
| – | – | ﹤0.01% | 271 |
|
|
2017
Q4 | $4K | Sell |
12
-47
| -80% | -$19K | ﹤0.01% | 377 |
|
|
2017
Q3 | $26K | Hold |
59
| – | – | 0.01% | 341 |
|
|
2017
Q2 | $29K | Sell |
59
-17
| -22% | -$7.44K | 0.02% | 156 |
|
|
2017
Q1 | $29K | Sell |
76
-84
| -53% | -$31.1K | 0.02% | 188 |
|
|
2016
Q4 | $59K | Buy |
+160
| New | +$60.8K | 0.04% | 152 |
|
Other funds holding REGN
Simon Quick Advisors's REGN Position: Q2 2026 in Review
Simon Quick Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 347 shares — an estimated $268K sold.
Simon Quick Advisors first reported a position in REGN in Q4 2016 and held it in 32 quarters. The position peaked at $1.11M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Simon Quick Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simon Quick Advisors sold 347 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $268K.
- Simon Quick Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 32 quarters.
- Simon Quick Advisors's Regeneron Pharmaceuticals position peaked at $1.11M in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.